title: First experiences with the use of rivaroxaban in the treatment of heparin-induced thrombocytopenia.
authors: Department of Haematology, Singapore General Hospital, 20 College Road, Singapore 169856, Republic of Singapore. Electronic address: ng.heng.joo@sgh.com.sg.
authors: H J
authors: HJ
authors: Ng
authors: Department of Haematology, Singapore General Hospital, 20 College Road, Singapore 169856, Republic of Singapore.
authors: H
authors: H
authors: Than
authors: Department of Haematology, Singapore General Hospital, 20 College Road, Singapore 169856, Republic of Singapore.
authors: E C Y
authors: EC
authors: Teo
mesh_terms: D000368:Aged; D001777:Blood Coagulation; D065427:Factor Xa Inhibitors / Q000627:therapeutic use*; D005260:Female; D006493:Heparin / Q000009:adverse effects*; D006494:Heparin Antagonists / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications; D008297:Male; D008875:Middle Aged; D009025:Morpholines / Q000627:therapeutic use*; D016491:Peripheral Vascular Diseases / Q000150:complications; D010976:Platelet Count; D006435:Renal Dialysis; D000069552:Rivaroxaban; D013876:Thiophenes / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000139:chemically induced / Q000188:drug therapy*; D020246:Venous Thrombosis / Q000150:complications
chemical_list: D065427:Factor Xa Inhibitors; D006494:Heparin Antagonists; D009025:Morpholines; D013876:Thiophenes; D006493:Heparin; D000069552:Rivaroxaban